Výsledky vyhledávání - "M F, Ozkaynak"

Akademický článek

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

Publikováno v: Frontiers in Immunology, Vol 8 (2017)

Killer-cell immunoglobulin-like receptors (KIRs) are a family of glycoproteins expressed primarily on natural killer cells that can regulate their function. Inhibitory KIRs recognize MHC class I molecules (KIR-ligands) as ligands. We have reported as

Externí odkaz: https://doaj.org/article/d5bf7e8e13a14ddfb5d4f0085470960e

Zobrazit plný text záznamu

A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders

Autor: Jerry Stein, Catherine H. Roberts, Tracey A. O'Brien, Hemalatha G. Rangarajan, Jignesh Dalal, Joseph R. Stanek, David M. Loeb, Caron Strahlendorf, Hyoung Jin Kang, Peter J. Shaw, Rolla Abu-Arja, Rakesh K. Goyal, Acw Lee, Lubna S Mehyar, Nabanita Bhunia, Shalini Shenoy, M. F. Ozkaynak

Publikováno v: Transfusion. 61:894-902

BACKGROUND Pleraxifor for peripheral blood stem cell (PBSC) mobilization in children with malignancies is often given following failure of standard mobilization (SM) rather than as a primary mobilizing agent. STUDY DESIGN AND METHODS In this retrospe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327408059602ea28a8ea63fe1769b276
https://doi.org/10.1111/trf.16260

Zobrazit plný text záznamu

Dinutuximab in the treatment of neuroblastoma

Autor: M. F. Ozkaynak

Publikováno v: Expert Opinion on Orphan Drugs. :1-8

Introduction: Neuroblastoma is the cancer of the sympathetic nervous system. Nearly half of the patients with neuroblastoma present with high-risk features and have poor outcome despite aggressive therapy. The high expression of GD2 – a cell surfac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0fa02d2c853d176f093d241cf424cb35
https://doi.org/10.1080/21678707.2017.1288094

Zobrazit plný text záznamu

Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032

Autor: Wendy B. London, Hiroyuki Shimada, Arlene Naranjo, Paul M. Sondel, Malcolm A. Smith, Andrew L. Gilman, Nita L. Seibel, Susan L. Cohn, Alice L. Yu, Rochelle Bagatell, Ami V. Desai, Sheena C. Tenney, M. F. Ozkaynak, John M. Maris, Katherine K. Matthay, Julie R. Park

Publikováno v: Journal of Clinical Oncology. 38:10523-10523

10523 Background: Immunotherapy with the anti-GD2 antibody dinutuximab plus sargramostim (GM-CSF), aldesleukin (IL-2) and isotretinoin following consolidation therapy improved outcome for high-risk neuroblastoma (HRNBL) pts enrolled on COG ANBL0032.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::636cfba1e575190a6abbfd9748057758
https://doi.org/10.1200/jco.2020.38.15_suppl.10523

Zobrazit plný text záznamu

Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipients

Autor: Olga Militano, Brinda Mehta, Mitchell S. Cairo, M. F. Ozkaynak, Carmella van deVen, Carl V. Hamby

Publikováno v: Pediatric bloodcancer. 65(8)

Background The optimal dose and schedule of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant recipients remains to be determined. We previously reported safety and pharmacokinetics of MMF at 900 mg/m2 q6h dosing. This study wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d35be9c343cb45c0115e86c5563e2cec
https://pubmed.ncbi.nlm.nih.gov/29667720

Zobrazit plný text záznamu

Acquired Thrombotic Thrombocytopenic Purpura in Children: A Single Institution Experience

Autor: Oya Levendoglu-Tugal, Somasundaram Jayabose, Claudio Sandoval, M. F. Ozkaynak, Theodore S. Nowicki, Julie Dunbar

Publikováno v: The Indian Journal of Pediatrics. 80:570-575

To describe the clinical features, treatment and prognosis of acquired thrombotic thrombocytopenic purpura (TTP) in children based on a single institution experience.This study is a retrospective review of all 12 children with TTP seen at New York Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d0f2f1664ea158be023cd8ea0d6ad0
https://doi.org/10.1007/s12098-012-0940-4

Zobrazit plný text záznamu

A Case of Relapsed Down Syndrome–Associated Acute Megakaryoblastic Leukemia Cured with Non-Myeloablative Chemotherapy

Autor: M. F. Ozkaynak, Sharon R. Pine, Claudio Sandoval, Oya Levendoglu-Tugal, Somasundaram Jayabose

Publikováno v: Clinical Leukemia. 1:309-312

Despite the excellent prognosis for patients with newly diagnosed Down syndrome–associated acute megakaryoblastic leukemia (DS-AMKL), patients with relapsed DS-AMKL have very poor prognosis, and there is no standard treatment for such patients. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ceeed64ca44eb8e92bbed9a0d6f189a9
https://doi.org/10.3816/clk.2007.n.023

Zobrazit plný text záznamu

Real-Time Quantitative PCR: Standardized Detection of Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia

Autor: Sharon R. Pine, Claudio Sandoval, Oya Levendoglu-Tugal, Somasundaram Jayabose, Joseph L. Wiemels, Fred H Moy, Ramneet K Gill, M. F. Ozkaynak

Publikováno v: Journal of Pediatric Hematology/Oncology. 25:103-108

Purpose To develop a standardized real-time polymerase chain reaction (PCR) method of quantifying minimal residual disease (MRD) in patients with pre-B acute lymphoblastic leukemia (ALL). Patients and methods In a series of 24 follow-up bone marrow (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09306c1c7066bd414177f905715fd452
https://doi.org/10.1097/00043426-200302000-00004

Zobrazit plný text záznamu

Telomere dynamics in childhood leukemia and solid tumors: a follow-up study

Autor: M. F. Ozkaynak, Oya Tugal, Somasundaram Jayabose, Malcom A.S. Moore, Sonia Franco, Claudio Sandoval, M Engelhardt

Publikováno v: Leukemia. 17:401-410

Telomeres of hematopoietic cells shorten with age, possibly contributing to the aging-associated hematopoietic pathology (immunosenescence, malignant transformation). Accelerated telomere shortening is seen with replicative stress, such as during adm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::289deefca271306e1fbc495435b866ab
https://doi.org/10.1038/sj.leu.2402815

Zobrazit plný text záznamu

Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia

Autor: Jorge A. Ortega, S Carcich, V I Avramis, M F Ozkaynak

Publikováno v: Medical and Pediatric Oncology. 31:475-482

Background The outcome of patients with acute myeloid leukemia (AML) who relapse or fail to achieve an initial remission has been dismal. Procedure Fifteen pediatric patients with AML, 4 relapsed and 11 primary refractory, were reinduced with a loadi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2895dd95ba8e23c0cd5a82e03c88b69
https://doi.org/10.1002/(sici)1096-911x(199812)31:6<475::aid-mpo3>3.0.co

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání